Financial Statements · Financial Reporting
Takeda Pharma OÜ
Official identifier 10323690Record date 31 Mar 2020
EstoniaReport
- Legal formThe legal or organisational form recorded by the Estonian Business Register. Learn more
- OÜ
- Report status
- Registered
Dates
- Reporting year
- 2019
- Period start
- 1 Apr 2019
- Submitted date
- 28 Sep 2020
Report
- Consolidated
- No
- Audited
- Yes
Financial metrics
| Statement | Metric | Value |
|---|---|---|
| Balance sheet | Assets | 24,944,000 |
| Balance sheet | Cash and cash equivalents | 98,000 |
| Balance sheet | Current assets | 24,863,000 |
| Balance sheet | Current liabilities | 5,674,000 |
| Balance sheet | Equity | 19,238,000 |
| Balance sheet | Share capital at nominal value | 141,000 |
| Balance sheet | Non-current assets | 81,000 |
| Balance sheet | Non-current liabilities | 32,000 |
| Balance sheet | Retained earnings (loss) from previous periods | 17,271,000 |
| Income statement scheme 1 | Depreciation and impairment of non-current assets | -44,000 |
| Income statement scheme 1 | Labour costs | -778,000 |
| Income statement scheme 1 | Revenue | 23,497,000 |
| Income statement scheme 1 | Annual period profit / loss | 599,000 |
| Income statement scheme 1 | Operating profit (loss) | 599,000 |
| Income statement scheme 1 | Profit (loss) before income tax | 599,000 |
| Profit distribution proposal | Retained earnings (loss) from previous periods | 17,271,000 |
| Note: Labour costs | Employees | 9 |
| Note: Labour costs | Labour costs | -779,000 |
| Rahavoogude aruanne kaudsel meetodil | Depreciation and impairment of non-current assets | 44,000 |
| Rahavoogude aruanne kaudsel meetodil | Operating profit (loss) | 599,000 |
Linked company
Company: Takeda Pharma OÜ